Order Article Reprints

AlZabali S, AlBatati S, Rahim K, Faqeehi H, Osman A, Bamhraz A, Saleh MA, Kari JA, Aloufi M, Eid L, et al. A Multicenter Study Evaluating the Discontinuation of Eculizumab Therapy in Children with Atypical Hemolytic Uremic Syndrome. Children. 2022; 9(11):1734. https://doi.org/10.3390/children9111734

AlZabali, Saeed, Sawsan AlBatati, Khawla Rahim, Hassan Faqeehi, Abubaker Osman, Abdulaziz Bamhraz, Mohammed A. Saleh, Jameela A. Kari, Majed Aloufi, Loai Eid, and et al. 2022. "A Multicenter Study Evaluating the Discontinuation of Eculizumab Therapy in Children with Atypical Hemolytic Uremic Syndrome" Children 9, no. 11: 1734. https://doi.org/10.3390/children9111734

AlZabali, S., AlBatati, S., Rahim, K., Faqeehi, H., Osman, A., Bamhraz, A., Saleh, M. A., Kari, J. A., Aloufi, M., Eid, L., Nasser, H., Imam, A., AlHammadi, E., Alkandari, O., Al Riyami, M., Sethi, S., Licht, C., Alhasan, K. A., & AlAnazi, A. (2022). A Multicenter Study Evaluating the Discontinuation of Eculizumab Therapy in Children with Atypical Hemolytic Uremic Syndrome. Children, 9(11), 1734. https://doi.org/10.3390/children9111734